Literature DB >> 16876165

Deeply infiltrating endometriosis affecting the rectum and lymph nodes.

Mauricio S Abrao1, Sergio Podgaec, Joao Antonio Dias, Marcelo Averbach, Ray Garry, Luis Fernando Ferraz Silva, Filomena M Carvalho.   

Abstract

OBJECTIVE: To analyze morphologic aspects of bowel endometriosis.
DESIGN: Prospective study of 35 consecutive cases of bowel endometriosis.
SETTING: Multidisciplinary group practice and teaching hospital. PATIENT(S): Thirty-five patients with bowel endometriosis were assessed between September 2003 and June 2005. INTERVENTION(S): Histologic analysis of 35 tissue samples removed at laparoscopic rectosigmoidectomy. MAIN OUTCOME MEASURE(S): We performed an evaluation of lesion size, number of lesions present in the bowel, intestinal wall layers affected by the endometriotic lesion, circumference of the intestinal loop affected by the endometriotic lesion, and presence of lymph nodes with foci of endometriosis. RESULT(S): Analysis of the surgical samples revealed lymph nodes in the pericolic adipose tissue of 19 (54%), cases and in 5 of these cases (26.3%), endometriosis had affected the lymph nodes. When the thickness of the endometriotic lesion reached 1.75 cm, lymph nodes of all patients were affected, and all patients in whom more than 80% of the circumference of the intestinal loop was affected by endometriosis presented with positive lymph nodes. CONCLUSION(S): This study raises doubts about whether this form of the disease can still be considered a clinically benign disease.

Entities:  

Mesh:

Year:  2006        PMID: 16876165     DOI: 10.1016/j.fertnstert.2006.02.102

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Endometriosis and regional lymph node involvement in a rat model.

Authors:  Yao Gong; Ling Hong; Chen-Chen Zheng; Xiao-Wen Tong; Clemens B Tempfer
Journal:  Wien Klin Wochenschr       Date:  2011-07-07       Impact factor: 1.704

2.  Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis.

Authors:  A J Hey-Cunningham; A T Fazleabas; A G Braundmeier; R Markham; I S Fraser; M Berbic
Journal:  Reprod Sci       Date:  2011-05-26       Impact factor: 3.060

Review 3.  Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects.

Authors:  Jian-Jun Wei; Josette William; Serdar Bulun
Journal:  Int J Gynecol Pathol       Date:  2011-11       Impact factor: 2.762

Review 4.  Deep endometriosis with pericolic lymph node involvement: a case report and literature review.

Authors:  Andrea Cacciato Insilla; Monnalisa Granai; Grazia Gallippi; Patrizia Giusti; Sabina Giusti; Simone Guadagni; Luca Morelli; Daniela Campani
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 5.  Recurrence of endometriosis after hysterectomy.

Authors:  B Rizk; A S Fischer; H A Lotfy; R Turki; H A Zahed; R Malik; C P Holliday; A Glass; H Fishel; M Y Soliman; D Herrera
Journal:  Facts Views Vis Obgyn       Date:  2014

6.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-positive lymph node endometriosis masquerading as lymph node metastasis of a malignant tumor.

Authors:  Makoto Akiyama; Izumi Suganuma; Taisuke Mori; Izumi Kusuki; Haruo Kuroboshi; Fumitake Ito; Hiroshi Matsushima; Morio Sawada; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-10

7.  A case of ileus caused by ileal endometriosis with lymph node involvement.

Authors:  Ryosuke Arata; Yuji Takakura; Satoshi Ikeda; Toshiyuki Itamoto
Journal:  Int J Surg Case Rep       Date:  2018-12-12

8.  MiRNA 34-a regulate SIRT-1 and Foxo-1 expression in endometriosis.

Authors:  Noha A Rezk; Mohamad Bakry Lashin; Norhan A Sabbah
Journal:  Noncoding RNA Res       Date:  2021-02-13

9.  ESR1 rs9340799 is associated with endometriosis-related infertility and in vitro fertilization failure.

Authors:  Diego Davila Paskulin; João Sabino Cunha-Filho; Livia Davila Paskulin; Carlos Augusto Bastos Souza; Patricia Ashton-Prolla
Journal:  Dis Markers       Date:  2013       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.